AGBK entered the week carrying an earnings print — and left it carrying a downgrade, a 13% loss, and questions about whether a top-line miss can be offset by credit discipline alone.
Q1 results landed on May 5. EPS of $0.26 beat the $0.25 consensus. Revenue of $260M missed the $275M estimate by a meaningful margin. The market's verdict was swift: the stock fell 3.5% on the day and has shed 12.6% across the week to close at $6.57. Within 24 hours, Itau BBA's Pedro Leduc — who had initiated coverage just two months earlier with an Outperform and a $15 target — cut the rating to Market Perform and announced a $9 target. The revision represents a 40% reduction from his March initiation price. That kind of rapid reversal from a lead analyst matters; it signals the Street's original thesis was more dependent on revenue growth than the headline EPS beat can sustain on its own.
The broader analyst picture adds context to that caution. When coverage launched in early March, it drew a cluster of bullish initiations: Morgan Stanley at Overweight with a $21 target, Citigroup at Buy with $18, Susquehanna at Positive with $17, and Oppenheimer at Outperform with $15. Those initiation targets now sit well above the current price of $6.57, and the data-consistency gap is wide enough to note: either the stock has de-rated dramatically in two months, or those initiations reflected early-listing optimism that has since been repriced. Leduc's revised $9 target is the only post-earnings anchor point, and it implies roughly 37% upside from current levels — though it also implies the analyst believes the stock belongs lower than any peer thought at launch. Valuation multiples tell the same story of compression: the price-to-book has dropped 11% over the past week to 0.87x, and the P/E has compressed by more than 0.5 turns in the same period to just 3.9x — both consistent with a market pricing in meaningful execution risk.
Short interest has been building steadily through this episode, though the borrow market does not yet suggest a crowded short. SI as a percentage of free float climbed from around 3.3% on April 23 to 5.7% by May 5 — nearly a 70% increase in roughly two weeks. Over the month, the estimated short count is up 77%. That is a meaningful acceleration. However, the lending environment remains loose: availability is running at over 2,000% of short interest, meaning there are roughly twenty shares available to borrow for every one currently lent out. Cost to borrow has actually eased since early April, falling from peaks above 12% to 7.7% — down 38% over the month. The ORTEX short score edged up to 43.2, its highest recent reading but still well below levels that would signal genuine squeeze pressure. The picture is one of growing but not extreme short conviction, against a backdrop of ample borrow supply.
Ownership concentration is worth flagging for anyone tracking liquidity dynamics. The top holder, Marciano Testa, controls 63% of shares. Vinci Capital holds a further 16%. Together, those two positions account for nearly 80% of the float, which means the tradeable pool is structurally thin. That concentration is not new — all reported positions reflect holdings from earlier in the year — but it frames the 12.6% weekly move and rising short interest in a different light. Thin floats amplify both the downside on bad news and the potential severity of any short covering.
There is a confirmed earnings event on May 28, and the recent track record adds context without offering comfort: the March 23 print was followed by an 8.2% one-day loss and a 19.8% five-day drawdown. With short interest rebuilding after the Q1 miss, the cost of borrow still relatively low, and the lead analyst now sidelined, the May 28 event is shaping up as the next inflection point for how the Street calibrates the gap between credit portfolio growth — Agibank's R$34.9B total credit book and R$2.5B FIDC structuring — and the revenue trajectory the market is now demanding.
See the live data behind this article on ORTEX.
Open AGBK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
